Timothy D. Ocain
Monterey College of Law(US)Takeda (United States)(US)Millennium Engineering and Integration (United States)(US)AstraZeneca (United States)(US)
Publications by Year
Research Areas
NF-κB Signaling Pathways, Peptidase Inhibition and Analysis, Signaling Pathways in Disease, Immune Response and Inflammation, Chemokine receptors and signaling
Most-Cited Works
- → NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ(2007)606 cited
- → Substrate-Based Design of the First Class of Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors(2002)187 cited
- → Rapamycin: A novel immunosuppressive macrolide(1994)167 cited
- → Mechanism-based approaches to treating fragile X(2010)123 cited
- → A Selective Small Molecule IκB Kinase β Inhibitor Blocks Nuclear Factor κB-Mediated Inflammatory Responses in Human Fibroblast-Like Synoviocytes, Chondrocytes, and Mast Cells(2006)112 cited
- → .alpha.-Keto amide inhibitors of aminopeptidases(1992)97 cited